124 related articles for article (PubMed ID: 22099718)
21. Exploring opportunities for collaboration between the corporate sector and the dental education community.
Alexander D; Clarkson J; Buchanan R; Chadwick G; Chesters R; Drisko CL; Douglass CW; Farrell L; Fletcher K; Makoni F; Monaco M; Nordquist B; Park NI; Riggs S; Schou L; Smales FC; Stamm JW; Toh CG; Volpe T; Ward P; Warren P
Eur J Dent Educ; 2008 Feb; 12 Suppl 1():64-73. PubMed ID: 18289269
[TBL] [Abstract][Full Text] [Related]
22. Guidelines on gifts to physicians from industry: an update.
American Medical Association. Council on Ethical and Judicial Affairs
Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909
[No Abstract] [Full Text] [Related]
23. Kickbacks, courtesies or cost-effectiveness?: Application of the Medicare antikickback Law to the marketing and promotional practices of drug and medical device manufacturers.
Bulleit TN; Krause JH
Food Drug Law J; 1999; 54(3):279-323. PubMed ID: 11797701
[TBL] [Abstract][Full Text] [Related]
24. The American "College" of Cardiology.
King SB
JACC Cardiovasc Interv; 2010 Mar; 3(3):365-6. PubMed ID: 20299001
[No Abstract] [Full Text] [Related]
25. Collaborations between surgeons and industry are productive and beneficial to patients.
Nakayama D
J Am Coll Surg; 2010 Jul; 211(1):146-7; author reply 147. PubMed ID: 20610270
[No Abstract] [Full Text] [Related]
26. Academia-industry collaboration in continuing medical education: description of two approaches.
Katz HP; Goldfinger SE; Fletcher SW
J Contin Educ Health Prof; 2002; 22(1):43-54. PubMed ID: 12004640
[TBL] [Abstract][Full Text] [Related]
27. Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.
Romano M
Mod Healthc; 2006 Jan; 36(5):8-10. PubMed ID: 16479773
[No Abstract] [Full Text] [Related]
28. US Senate committee investigates conflicts of interest in industry funded medical education.
Tanne JH
BMJ; 2009 Aug; 339():b3139. PubMed ID: 19654162
[No Abstract] [Full Text] [Related]
29. Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a policy statement from the European Society of Cardiology.
ESC Board
Acta Cardiol; 2012 Jun; 67(3):379-90. PubMed ID: 22870754
[TBL] [Abstract][Full Text] [Related]
30. Transparency of industry payments needed in clinical practice guidelines.
Vassar M; Bibens M; Wayant C
BMJ Evid Based Med; 2019 Feb; 24(1):8-9. PubMed ID: 30042209
[No Abstract] [Full Text] [Related]
31. The relationship between paediatricians and commerce.
Hilliard T; Chambers T
Paediatr Respir Rev; 2006 Mar; 7(1):54-9. PubMed ID: 16473818
[TBL] [Abstract][Full Text] [Related]
32. [The medical-industrial complex: an ethical challenge].
Engelhardt K
Dtsch Med Wochenschr; 2005 Jul; 130(30):1778-80. PubMed ID: 16049885
[No Abstract] [Full Text] [Related]
33. Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
Zoorob R; Larzelere M
J La State Med Soc; 2004; 156(1):28-32. PubMed ID: 15000210
[TBL] [Abstract][Full Text] [Related]
34. Pharmaceutical industry and payer partnerships to manage costs and improve quality.
Mauch RP
Manag Care; 2001 Sep; 10(9 Suppl):2-4; discussion 9-12. PubMed ID: 11729438
[No Abstract] [Full Text] [Related]
35. Guidelines for collaboration of industry and surgical organizations in support of research and continuing education.
Committee on Ethics, American College of Surgeons
Bull Am Coll Surg; 2001 May; 86(5):30-1. PubMed ID: 12298364
[No Abstract] [Full Text] [Related]
36. The role of the medical science liaison in industry.
Baker DL
AORN J; 2010 Mar; 91(3):394-8. PubMed ID: 20193805
[TBL] [Abstract][Full Text] [Related]
37. Facilitating product development.
Lanser EG
Healthc Exec; 2001; 16(3):62-3. PubMed ID: 11372237
[No Abstract] [Full Text] [Related]
38. Role of the industry sponsor: protection of human subjects in early device-application studies.
Oleson KA
J Lab Clin Med; 2005 Jan; 145(1):17-20. PubMed ID: 15668657
[TBL] [Abstract][Full Text] [Related]
39. Antitrust enforcement in pharmaceutical industry mergers.
Balto DA; Mongoven JF
Food Drug Law J; 1999; 54(3):255-78. PubMed ID: 11797700
[No Abstract] [Full Text] [Related]
40. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
Studdert DM; Mello MM; Brennan TA
N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
